[Asp371]-Tyrosinase (369-377), human
[Asp371]-Tyrosinase (369-377), human
Tyrosinase 369-377, human is a HLA-A2.1-restricted epitope derived from tyrosinase, has been used to develop tumor-targeted vaccines with mixed efficacy.
Online Inquiry
| CAT# | R1116 |
| CAS | 168650-46-2 |
| Synonyms/Alias | Tyrosinase |
| M.F/Formula | C₄₂H₆₆N₁₀O₁₆S₂ |
| M.W/Mr. | 1031.16 |
| Sequence | One Letter Code: YMDGTMSQV
three Letter Code: Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val |
| Areas of Interest | Antigen-presenting Cells; Cancer Research |
| Disease | Melanoma |
| Source# | Homo sapiens (human) |
Storage | Common storage 2-8℃, long time storage -20℃. |
Restricting HLA | HLA-A2 |
References | Zhigang Wang; Cell Transplant 2015 |
Write a review
Ask a question
My Review for [Asp371]-Tyrosinase (369-377), human
Required fields are marked with *
×
Ask a Question for [Asp371]-Tyrosinase (369-377), human
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
